Meyka Pro banner
Innovage Holding Corp.

Innovage Holding Corp. (NASDAQ: INNV) Stock Competitors & Peer Comparison

See INNV's competitors and their performance on the NASDAQ and across the wider stock market.

INNVNASDAQ
HealthcareMedical - Care Facilities
$11.47
$0.34(2.88%)
U.S. Market opens in 10h 16m

Peer Comparison Table: Medical - Care Facilities Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for INNV and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
INNV$11.56+3.31%1.6B-128.44-$0.09N/A
HCA$382.19+1.51%84.8B13.20$28.96+0.78%
THC$233.20+17.17%20.1B13.53$17.24N/A
DVA$235.44+0.50%15.1B20.06$11.73N/A
SOLV$78.01+1.00%13.5B12.50$6.24N/A
FMS$24.59+0.61%13.2B9.76$2.52+3.52%
EHC$112.89+1.65%11.2B19.83$5.69+0.67%
ENSG$172.99+3.27%10.1B25.07$6.90+0.15%
UHS$155.75+2.96%9.8B6.91$22.54+0.51%
OSH$39.00+0.08%9.5B-17.65-$2.21N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HCA Healthcare, Inc. (NYSE: HCA)

INNV vs HCA Comparison July 2026

Innovage Holding Corp. (NASDAQ: INNV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, INNV stands at 1.6B. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, INNV is priced at $11.56 on the NASDAQ, while HCA trades at $382.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

INNV currently has a P/E ratio of -128.44, whereas HCA's P/E ratio is 13.20. In terms of profitability, INNV's ROE is -0.09%, compared to HCA's ROE of -1.54%. Regarding short-term risk, INNV is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for INNV.Check HCA's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions